Comment: prophylaxis for RSV hospitalization may not be cost-saving.
Vergouwe
Yvonne
Y
Steyerberg
Ewout W
EW
Rietveld
Edwin
E
Moll
Henriëtte A
HA
D003362:Cost-Benefit Analysis / Q000191:economics*; D006760:Hospitalization / Q000191:economics*; D006801:Humans; D007231:Infant, Newborn; D018357:Respiratory Syncytial Virus Infections / Q000191:economics* / Q000517:prevention & control